Thursday, December 24, 2020

Third phase of Covaxin’s clinical trials begins at research institute

Based on the results of the trial, vaccine may be licensed commercially in early 2021, says MGMCRI

from The Hindu - News https://ift.tt/2WG8iAS
Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)